Driehaus Capital Management LLC Dice Therapeutics, Inc. Transaction History

Driehaus Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $949,165 - $1.71 Million	36,704 Added 1.83%	2,038,257 $94.7 Million
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $1.25 Million - $1.55 Million	47,847 Added 2.45%	2,001,553 $57.3 Million
Q4 2022 Feb 14, 2023	SELL	$19.77 - $42.23 $357,579 - $763,814	-18,087 Reduced 0.92%	1,953,706 $61 Million
Q3 2022 Nov 14, 2022	SELL	$14.97 - $22.65 $3.87 Million - $5.86 Million	-258,745 Reduced 11.6%	1,971,793 $40 Million
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $1.39 Million - $2.33 Million	105,310 Added 4.96%	2,230,538 $34.6 Million
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $311,359 - $535,778	-21,414 Reduced 1.0%	2,125,228 $40.7 Million
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $2.09 Million - $3.5 Million	93,242 Added 4.54%	2,146,642 $54.3 Million
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $65.5 Million - $76 Million	2,053,400 New	2,053,400 $67.2 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.